Innovative Clinical Research Institute ( Site 0122) — Whittier, California

Innovative Clinical Research Institute ( Site 0122) is a clinical research site located in Whittier, California, United States 90603.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Innovative Clinical Research Institute ( Site 0122) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: DLBCL, Diffuse Large B-Cell Lymphoma.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Innovative Clinical Research Institute ( Site 0122)?

Innovative Clinical Research Institute ( Site 0122) has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Innovative Clinical Research Institute ( Site 0122) conducted?

Innovative Clinical Research Institute ( Site 0122) has 1 clinical trials on record, with 1 currently active. Their work covers DLBCL, Diffuse Large B-Cell Lymphoma.

Is Innovative Clinical Research Institute ( Site 0122) accredited by Crixeo Health?

Innovative Clinical Research Institute ( Site 0122) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Innovative Clinical Research Institute ( Site 0122)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.